Ryne Biotechnology receives CIRM grant to advance RNDP-001

RNDP-001 is an iPSC-derived dopamine neuron progenitor intended to treat inherited as well as idiopathic forms of Parkinson’s disease. Credit: Natasha Connell on Unsplash.